Nicorette Mint Mentolos (Nicotine)

Nicotine, the active ingredient in Nicorette Mint Mentolos, is a nicotine replacement therapy presented as a form for oromucosal use. It is used to aid smoking cessation in adults who are motivated to quit. GNH USA supplies Nicorette Mint Mentolos as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies worldwide.

Nicorette Mint Mentolos is a nicotine replacement product that supports the smoking cessation pathway. - Smoking cessation: helps reduce nicotine withdrawal symptoms and cravings, facilitating a gradual transition away from cigarettes.

Nicorette Mint Mentolos may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Mouth irritation: mild soreness or tingling in the oral cavity. - Nausea: occasional upset stomach or feeling of queasiness. - Headache: mild to moderate headache during initial use. - Dyspepsia: indigestion or heartburn. - Hiccups: brief episodes of involuntary diaphragmatic contractions. - Increased salivation: temporary excess saliva production.

Serious or Rare Side Effects: - Cardiovascular events: chest pain, palpitations, or hypertension. - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Persistent dizziness: prolonged vertigo or loss of balance. - Gastrointestinal ulceration: rare stomach or intestinal ulcer development.

When using Nicorette Mint Mentolos, consider the following safety measures. - Cardiovascular disease: assess risk before initiating therapy. - Pregnancy and lactation: consult a healthcare professional; safety not established. - Pediatric use: not recommended for children or adolescents. - Concomitant nicotine products: avoid using other nicotine sources simultaneously. - Storage: Store at ambient temperature below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Nicotine may interact with several drug classes; awareness of potential interactions helps ensure safe use.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may increase hypertensive response. - Beta‑blockers: nicotine can blunt therapeutic effects on heart rate.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs, SNRIs): monitor for increased anxiety or insomnia. - Antihypertensives: observe blood pressure for possible elevation. - Caffeine‑containing products: may enhance stimulant effects, leading to jitteriness.